0.12Open0.12Pre Close0 Volume0 Open Interest15.00Strike Price0.00Turnover6354.83%IV185.01%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.12Extrinsic Value100Contract SizeAmericanOptions Type0.0957Delta0.0501Gamma44.21Leverage Ratio-7.4809Theta0.0000Rho4.23Eff Leverage0.0001Vega
Prime Medicine Stock Discussion
Down -12%
Net Inflow 154.87
XL in 136.33
XL out 0
$Prime Medicine(PRME.US)$ $NVIDIA(NVDA.US)$
• Editing Genes | $CRISPR Therapeutics(CRSP.US)$ , $Intellia Therapeutics(NTLA.US)$ , $Beam Therapeutics(BEAM.US)$ , $Verve Therapeutics(VERV.US)$ , $Editas Medicine(EDIT.US)$
• Creating Therapies | $Prime Medicine(PRME.US)$ , $Sana Biotechnology(SANA.US)$
• Building DNA | $Twist Bioscience(TWST.US)$ , $Ginkgo Bioworks(DNA.US)$ , $Pacific Biosciences of California(PACB.US)$ , $Illumina(ILMN.US)$
• Dis...
NEWS
Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
No comment yet